NEWSROOM

KaliExtracts

KALY Previews Investment Commitment Into Its Cannabis Biopharmaceutical Technology

Aug 7, 2020

Dallas, TX – February 3, 2020 - Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC PINK: KALY) (“KALY”) today previewed a letter of intent (LOI) executed with a third-party investor. The LOI details are anticipated to be released tomorrow. Management indicates the two-stage investment is of substantial magnitude and can meaningfully advance the company’s ongoing development of its cannabis biopharmaceutical technology. KALY has a U.S. Patented Cannabis Extraction Process it uses to...

read more

KALY Patented Cannabis Biotech $50 Million Valuation Supported By Analyst Assessment Of Cannabis Pharmaceuticals Driving $66 Billion Sector

Aug 7, 2020

Dallas, TX – January 31, 2020 - Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC PINK: KALY) (“KALY”) today pointed to a Grand View Research report on the legal marijuana market projecting the legal marijuana market to reach over $66 Billion in value by 2025 to support a recent $50 Million valuation of KALY’s cannabis biotechnology. KALY has U.S. Patented Cannabis Extraction Process it uses to produce proprietary formulations for the treatment of various medical conditions. Grand...

read more

KALY-Kali-Extracts Proprietary CBD Extract Could Offer Coronavirus Relief

Aug 7, 2020

Dallas, TX – January 29, 2020 - Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC PINK: KALY) (“KALY”) today confirmed efforts to evaluate its proprietary CBD extract formulation as a treatment for coronavirus symptoms. KALY’s proprietary CBD formulation has been developed for the treatment of symptoms associated with Chronic Obstructive Pulmonary Disease (COPD) and other similar respiratory conditions. The formulation for the treatment of symptoms associated with COPD and other...

read more

Categories

Mcap MediaWire - Costumer Service

Translate »